A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.

• मुख्य लेखकों: Adebola Tolulope Olayinka (लेखक), Josephine Bourner (लेखक), George O Akpede (लेखक), Joseph Okoeguale (लेखक), Chukwuyem Abejegah (लेखक), Nnennaya A Ajayi (लेखक), Christian Akude (लेखक), Oluwafemi Ayodeji (लेखक), Daniel G Bausch (लेखक), Hilde de Clerck (लेखक), Chioma Dan-Nwafor (लेखक), Jake Dunning (लेखक), Cyril Erameh (लेखक), Justus Ndulue Eze (लेखक), Pierre Formenty (लेखक), Annelies Gillesen (लेखक), Sulaiman Jalloh (लेखक), Marie Jaspard (लेखक), Tolulope Jegede (लेखक), Jacob Maikere (लेखक), Denis Malvy (लेखक), Ephraim Ogbaini-Emovon (लेखक), Olalekan Ezekial Ojo (लेखक), Sylvanus Okogbenin (लेखक), Kwame O'Neill (लेखक), Maria-Lauretta Orji (लेखक), Sampson Omagbemi Owhin (लेखक), Michael Ramharter (लेखक), Robert J Samuels (लेखक), Nathan Shehu (लेखक), Laura Merson (लेखक), Alex Paddy Salam (लेखक), Nzelle Delphine Kayem (लेखक), Peter Horby (लेखक), Chikwe Ihekweazu (लेखक), Piero Olliaro (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Public Library of Science (PLoS), 2022-01-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

<h4>Background</h4>Only one recommendation currently exists for the treatment of Lassa fever (LF), which is ribavirin administered in conjunction with supportive care. This recommendation is primarily based on evidence generated from a single clinical trial that was conducted more than 3...